机构:[1]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China[2]Southern Medical University, Guangzhou, 510000, China[3]Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China[4]Department of Dermatovenereology, Foshan Women and Children Hospital, Guangdong, 528000, China[5]Department of Gynecology, The First People's Hospital of Huizhou City, Guangdong, 516000, China[6]Department of Gynecology Oncology, The Memorial Hospital of Sun Yat-sen University, Guangzhou, 510000, China[7]Department of Gynecology, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China
This work was supported by the Guangdong Provincial Medical
Research Fund (grant no. A2019096), the Guangdong Provincial
Traditional Chinese Medicine Bureau Fund (grant no. 20201220), the
President funds of Integrated Hospital of Traditional Chinese Medicine,
Southern Medical University (No. 1201902001; No. 1201901002), the
High-Level Academic Talent Training Program of Guangzhou Medical
University (No. B185004083; No. B195001100), Guangzhou Science
and Information Bureau Item (grant no. 201904010013), Natural
Science Foundation of Guangdong Province (grant no.
2018A0303130180) and Hospital achievement transformation and
Cultivation Project (grant no. ZH201812).
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类|3 区医学
小类|3 区医学:研究与实验3 区药学
最新[2025]版:
大类|2 区医学
小类|2 区医学:研究与实验2 区药学
JCR分区:
出版当年[2018]版:
Q1PHARMACOLOGY & PHARMACYQ2MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[1]Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China[2]Southern Medical University, Guangzhou, 510000, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Liu Longyang,Ning Yingxia,Yi Juanjuan,et al.miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.[J].BIOMEDICINE & PHARMACOTHERAPY.2020,125:doi:10.1016/j.biopha.2020.109865.
APA:
Liu Longyang,Ning Yingxia,Yi Juanjuan,Yuan Jianhuan,Fang Weiyi...&Zeng Zhaoyang.(2020).miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression..BIOMEDICINE & PHARMACOTHERAPY,125,
MLA:
Liu Longyang,et al."miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.".BIOMEDICINE & PHARMACOTHERAPY 125.(2020)